Erythrocyte sedimentation rate kinetics as a marker of treatment response and predictor of prognosis in Chinese metastatic renal cell carcinoma patients treated with sorafenib
スポンサーリンク
概要
- 論文の詳細を見る
- 2011-06-01
著者
-
Zhu Yao
Department Of Industrial And Systems Engineering The Hong Kong Polytechnic University
-
Yao Xu-dong
Department Of Urology Fudan University Shanghai Cancer Center
-
ZHANG Hai-Liang
Department of Urology, Fudan University Shanghai Cancer Center
-
WANG Chao-Fu
Department of Pathology, Fudan University Shanghai Cancer Center
-
ZHANG Shi-Lin
Department of Urology, Fudan University Shanghai Cancer Center
-
DAI Bo
Department of Urology, Fudan University Shanghai Cancer Center
-
SHEN Yi-Jun
Department of Urology, Fudan University Shanghai Cancer Center
-
ZHU Yi-Ping
Department of Urology, Fudan University Shanghai Cancer Center
-
SHI Guo-Hai
Department of Urology, Fudan University Shanghai Cancer Center
-
YE Ding-Wei
Department of Urology, Fudan University Shanghai Cancer Center
-
Shen Yi-jun
Department Of Urology Fudan University Shanghai Cancer Center
-
Shi Guo-hai
Department Of Urology Fudan University Shanghai Cancer Center
-
Zhu Yi-ping
Department Of Urology Fudan University Shanghai Cancer Center
-
Wang Chao-fu
Department Of Pathology Fudan University Shanghai Cancer Center
-
Zhang Hai-liang
Department Of Urology Fudan University Shanghai Cancer Center
-
Ye Ding-wei
Department Of Urology Fudan University Shanghai Cancer Center
-
Dai Bo
Department Of Urology Fudan University Shanghai Cancer Center
-
Zhang Shi-lin
Department Of Urology Fudan University Shanghai Cancer Center
-
Zhu Yao
Department Of Urology Fudan University Shanghai Cancer Center
-
DAI Bo
Department of Computer Science, Purdue University
関連論文
- General Rule of Phase Decomposition in Zn-Al Based Alloys (II) : On Effects of External Stresses on Phase Transformation
- Erythrocyte sedimentation rate kinetics as a marker of treatment response and predictor of prognosis in Chinese metastatic renal cell carcinoma patients treated with sorafenib
- Squared-loss Mutual Information Regularization
- Squared-loss Mutual Information Regularization